ERIN CRAIN: Open Payments
NPI 1467096958 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,934 in 86 payments from 18 companies in 2025. Trend: 2023 $2,549 · 2024 $2,201 · 2025 $1,934
Food & beverage: $1,915Travel & lodging: $19
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $265 |
| GENZYME CORPORATION | 6 | $205 |
| ABBVIE INC. | 12 | $202 |
| Galderma Laboratories, L.P. | 10 | $177 |
| Janssen Biotech, Inc. | 9 | $173 |
| Novartis Pharmaceuticals Corporation | 5 | $149 |
| PFIZER INC. | 7 | $135 |
| Arcutis Biotherapeutics, Inc. | 6 | $116 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $106 |
| Incyte Corporation | 4 | $84 |
Products named: DUPIXENT, TREMFYA, EBGLYSS, CIBINQO, SKYRIZI, TALTZ, Zoryve, OPZELURA.
Industry payments across IL — which companies pay providers there.
